(NaturalNews) Massive public outcry against the US Food and Drug Administration’s (FDA) proposed guidelines for New Dietary Ingredients (NDI) in supplements appears to be having a significant impact, as the agency recently announced a 60-day extension period for the public to submit comments on the issue. This means that now is the time to petition everyone you know to bombard the agency with concerted opposition to its proposed takeover of the supplement industry.
In case you missed it, the FDA back in July proposed new notification guidelines for handling new dietary supplement ingredients and ingredient blends created after the passage of the Dietary Supplement Health and Education Act of 1994 (DSHEA).
However, the proposals, which come from mandates attached to DSHEA, actually contradict the legislation’s notification provisions by turning them into an FDA approval process similar to what drugs must undergo (http://www.naturalnews.com/032924_dietary_supplements_FDA_approval.html).
In essence, the FDA has basically proposed a plan to hijack the entire supplement industry, and force it to comply with a non-existent approval process that was never a part of DSHEA, and that was never intended to pass by Congress. And if the agency gets the proposal passed as is, many of the supplements used today by millions will likely be forced off the market, not to mention their producers run out of business.
But it appears that, because of widespread publicity about the FDA’s sinister plot, the agency has decided to extend the comment period for its “Dietary Supplements: New Dietary Ingredient Notifications and Related Issues.” So the public now has until December 2 to submit comments pertaining to the proposal.
This is great news, of course, as it gives the natural health community more than enough time to let the FDA know that we are watching and listening, and that we do not approve of its little scheme. We absolutely must join together now, and tell the FDA to keep its hands off our supplements!
To view the FDA proposal for yourself, and to submit electronic comments, visit: http://www.regulations.gov/#!documentDetail;D=FDA-2011-D-0376-0079